BioSpace News Archive

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021 .

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced the commercial availability of its novel product PEMFEXY™ (pemetrexed for injection).

ObsEva SA, a biopharmaceutical company developing and commercializing novel therapies for women’s health, announced the appointment of Katja Buhrer as Chief Strategy Officer and member of the company’s Executive Committee, effective February 1, 2022.

Microbix Biosystems Inc. announces the expansion of its portfolio of Quality Assessment Products to include a swab-formatted control that helps validate the accuracy and integrity of the workflows of nucleic-acid based tests for SARS-CoV-2 Wuhan strain and the Omicron variant – the latter now being the most prevalent form of COVID.

PharmaTher Holdings Ltd. is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation (“ODD”) for ketamine to treat Status Epilepticus (“SE”), a rare neurological disorder requiring emergency treatment for a seizure.

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Anavex Life Sciences today reported positive top-line results from the Phase 3 randomized, double-blind, placebo-controlled AVATAR trial of ANAVEX®2-73

Purity Scientific LLC announced that it has acquired Conquer Scientific.

CytoSorbents Corporation announced today that the first patient has been enrolled in the PROCYSS trial in Germany by Prof. Dr. Stefan Kluge, Director, Department of Intensive Care Medicine at the University Hospital Hamburg Eppendorf and lead investigator of the PROCYSS trial.

ZAP Surgical Systems, Inc. today announced installation of its first ZAP-X® Gyroscopic Radiosurgery® platform in Japan.